Armstrong Michael F, O'Byrne Thomas J, Calva Jason J, Mallory Molly J, Bublitz Sara E, Do Alexander, Pinheiro Neto Carlos D, Choby Garret W, O'Brien Erin K, Bauer Brent A, Stokken Janalee K
Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, MN, USA.
Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
Glob Adv Integr Med Health. 2025 May 14;14:27536130251343834. doi: 10.1177/27536130251343834. eCollection 2025 Jan-Dec.
Olfactory dysfunction (OD) is a common symptom in patients with coronavirus disease 2019 (COVID-19) with limited treatment options.
This pilot study aimed to investigate an acupuncture protocol in patients with COVID-19 related OD.
Thirty patients were randomized into 2 groups. The standard group was treated with budesonide nasal irrigation and olfactory training. The acupuncture group received ten sessions of acupuncture therapy in addition to the standard group treatment. Olfaction was assessed using the University of Pennsylvania Smell Identification Test, 10-point visual analog scale, and Sino-Nasal Outcome Test at baseline and after 3 months of treatment. Differences between study arms were compared using Fisher's exact and Wilcoxon rank sum tests.
Eighteen of the 30 (60%) enrolled patients completed the study, including 11 (73%) in the standard and 7 (47%) in the acupuncture group. Reasons for participant drop-out included cost of travel and time constraints. There were no acupuncture complications.
Acupuncture as an adjunct therapy for COVID-19 related OD is well tolerated. Subsequent studies with larger sample sizes are needed to assess the effect of acupuncture on OD.
嗅觉功能障碍(OD)是2019冠状病毒病(COVID-19)患者的常见症状,治疗选择有限。
这项初步研究旨在调查针对COVID-19相关嗅觉功能障碍患者的针灸方案。
30名患者被随机分为两组。标准组接受布地奈德鼻腔冲洗和嗅觉训练。针灸组除标准组治疗外,还接受十次针灸治疗。在基线和治疗3个月后,使用宾夕法尼亚大学嗅觉识别测试、10分视觉模拟量表和鼻-鼻窦结局测试评估嗅觉。使用Fisher精确检验和Wilcoxon秩和检验比较研究组之间的差异。
30名入组患者中有18名(60%)完成了研究,其中标准组11名(73%),针灸组7名(47%)。参与者退出的原因包括差旅费和时间限制。未出现针灸并发症。
针灸作为COVID-19相关嗅觉功能障碍的辅助治疗耐受性良好。需要后续更大样本量的研究来评估针灸对嗅觉功能障碍的影响。